Hidalgo M, Plaza C, Musteanul M, lllei P, Brachmanna C B, Heisea C, Piercea D, Lopez-Casasr PP, Menendezl C, Taberneros J, Romano A, Weia X, Lopez-Rios F, and Von Hoff DD. SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel Plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase lll MPACT Trial. Clin Cancer Res. 2015 Nov 1;21(21):4811-8. - Stand Up To Cancer

Blog

Posted September 12, 2019

Hidalgo M, Plaza C, Musteanul M, lllei P, Brachmanna C B, Heisea C, Piercea D, Lopez-Casasr PP, Menendezl C, Taberneros J, Romano A, Weia X, Lopez-Rios F, and Von Hoff DD. SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel Plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase lll MPACT Trial. Clin Cancer Res. 2015 Nov 1;21(21):4811-8.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.